Theoretical model of SH2-dependent STAT1 dimerization as a novel tool to identify specific compounds of functional inhibition

2012/07/N/NZ2/01359

Keywords

Descriptors

  • NZ2_7: Bioinformatyka
  • NZ1_9: Biotechnologia
  • ST4_15: Chemia teoretyczna i obliczeniowa

Panel

NZ2 – Genetics, genomics: molecular genetics, genomics, proteomics, bioinformatics, systems biology, genetic epidemiology

Host institution

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

Voivodeship: wielkopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Małgorzata Szeląg

Number of co-investigators in the project: 3

Call

PRELUDIUM 4 – announced on 2012-09-15

Amount awarded
150 000 PLN
Project start date
2013-07-17
Project end date
2016-07-16
Project duration
36 months (the same as in the proposal)
Project status
Project settled

Equipment purchased [PL]

  1. Komputer wieloprocesorowy z monitorem 27-calowym. Cost: 6 000 PLN

Information in the final report

Publication in academic press/journals (7)

  1. Comparative screening and validation as a novel tool to identify STAT-specific inhibitors

    Authors:
    Szeląg M., Czerwoniec A., Wesoły J., Bluyssen H.A.R.
    Academic press:
    European Journal of Pharmacology (year: 2014, volume: 740, pages: 417-420), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.ejphar.2014.05.047 – link to the publication
  2. Identyfication of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation

    Authors:
    Szeląg M., Czerwoniec A., Wesoły J., Bluyssen H.A.R.
    Academic press:
    PLoS One (year: 2015, volume: 10(2), pages: e0116688), Publisher: Public Library of Science
    Status:
    Published
    DOI:
    10.1371/journal.pone.0116688 – link to the publication
  3. Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease

    Authors:
    Szelag M, Piaszyk-Borychowska A, Plens-Galaska M, Wesoly J, Bluyssen HAR
    Academic press:
    Oncotarget (year: 2016, volume: 7(30), pages: 48788-48812), Publisher: Impact Journals
    Status:
    Published
    DOI:
    10.18632/oncotarget.9195 – link to the publication
  4. CAVS – Novel in silico selection strategy of specific STAT inhibitory compounds

    Authors:
    Czerwoniec A., Szelag M., Juszczak K., Wesoly J., Bluyssen H.A.R.
    Academic press:
    Journal of Computational Science (year: 2015, volume: -, pages: -), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.jocs.2015.03.001 – link to the publication
  5. Advances in peptidic and peptidomimetic-based approaches to inhibit STAT signaling in human diseases

    Authors:
    Szelag M., Wesoly J., Bluyssen H.A.R.
    Academic press:
    Current Protein and Peptide Science (year: 2016, volume: 17, pages: 135-146), Publisher: Bentham Science
    Status:
    Published
    DOI:
    10.2174/1389203716666151102103706 – link to the publication
  6. In silico simulations of STAT1 and STAT3 inhibitors predict SH2 domain cross-binding specificity

    Authors:
    Szeląg M., Sikorski K., Czerwoniec A., Szatkowska K., Wesoły J., Bluyssen H.A.R.
    Academic press:
    European Journal of Pharmacology (year: 2013, volume: 720, pages: 38-48), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.ejphar.2013.10.055 – link to the publication
  7. A theoretical antioxidant pharmacophore for natural hydroxycinnamic acids

    Authors:
    Szelag M., Urbaniak A., Bluyssen H.A.R.
    Academic press:
    Open Chemistry (year: 2015, volume: 13, pages: 17-31), Publisher: De Gruyter
    Status:
    Published
    DOI:
    10.1515/chem-2015-0001 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski